ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Preventing Loss of Vision with CRISPR | Technology Networks – Technology Networks

Preventing Loss of Vision with CRISPR | Technology NetworksTechnology NetworksGreen fluorescence indicating Nrl gene expression in mouse retina. Upper panel showing normal Nrl expression. Bottom panel showing reduced Nrl expression&nbsp… Continue reading

2017-03-15 Michael Zand NEWS

From skin to brain: Stem cells without genetic modification – Phys.Org

Phys.OrgFrom skin to brain: Stem cells without genetic modificationPhys.OrgStem cells have been derived from adult cells before, but not without adding genes to alter the cells. The new process yields neural crest cells without addition of foreign gene… Continue reading

2017-03-15 Michael Zand NEWS

Chinese scientists repair viable human embryos with CRISPR for first time – Genetic Literacy Project

Continue reading

2017-03-15 Michael Zand NEWS

Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease – Labiotech.eu (blog)


Genetic Literacy Project

Chinese scientists repair viable human embryos with CRISPR for first time
Genetic Literacy Project
Until now, results have only been published from experiments in which the CRISPR technique was used in abnormal embryos, made when two sperm fertilize the same egg…However, these experiments may not have given an accurate indication of how well …

Continue reading

2017-03-15 Michael Zand NEWS

Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease – Labiotech.eu (blog)

ForbesAllergan makes a deal with Editas to License CRISPR Programs for Eye DiseaseLabiotech.eu (blog)Allergan has signed a deal with Editas Medicine to access its CRISPR technology and license up to five of its programs in ocular disease. The Irish All… Continue reading

2017-03-15 Michael Zand NEWS

Immunotherapy in the Twentieth Century: William Coley and Lloyd J. Old – Cancer Therapy Advisor

Cancer Therapy AdvisorImmunotherapy in the Twentieth Century: William Coley and Lloyd J. OldCancer Therapy AdvisorThe theory that the immune system is intimately involved in controlling cancer and, in some cases, promoting the development of cancer is … Continue reading

2017-03-15 Michael Zand NEWS

Kiadis to Present Promising Data from T-cell Therapy for Stem Cell Transplants in Patients with Blood Disorders – Lymphoma News Today

Kiadis to Present Promising Data from T-cell Therapy for Stem Cell Transplants in Patients with Blood DisordersLymphoma News TodayPatients undergoing allogeneic (donor) stem cell transplants may benefit from treatment with ATIR101, a form of T-cells th… Continue reading

2017-03-15 Michael Zand NEWS

Kiadis to Present Promising Data from T-cell Therapy for Stem Cell Transplants in Patients with Blood Disorders – Lymphoma News Today

Kiadis to Present Promising Data from T-cell Therapy for Stem Cell Transplants in Patients with Blood DisordersLymphoma News TodayPatients undergoing allogeneic (donor) stem cell transplants may benefit from treatment with ATIR101, a form of T-cells th… Continue reading

2017-03-15 Michael Zand NEWS
  • 1
  • …
  • 1,974
  • 1,975
  • 1,976
  • 1,977
  • 1,978
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease
Labiotech.eu (blog)
With this new deal, Allergan will access both CRISPR/Cas9 and CRISPR/Cpf1 versions of the technology. The great potential of the technology has spurred a fierce battle between two parties over the ownership of the technology’s IP. Recently, the US …
Allergan And Editas Medicine Enter Into R&D AllianceBio-IT World
Allergan (AGN) and Editas Tie Up to Treat Eye DiseasesZacks.com
Pre-Movers Stocks In Imitation: Allergan plc (NYSE:AGN), Endo International plc (NASDAQ:ENDP)Street Wise Report (blog)

all 109 news articles »